Tagged with sweden

Sweden Ascelia Pharma is a Swedish oncology start-up based in Malmö. CEO Magnus Corfitzen talks about the opportunities they have found in the orphan oncology drug market, the promising phase III study for their lead asset, Mangoral, and his journey navigating the Swedish life science industry.   With Mangoral, we are…

Sweden Olav Fromm, managing director of Chiesi Nordics, explains the deep roots of Chiesi in Sweden, where its blockbuster drug, a surfactant for treating neonatal babies, was developed. He also touches upon the strategic importance of the region to Chiesi, with the recent creation of a fully-fledged Nordic subsidiary, which will…

Sweden Having more than 20 years’ experience in the beverage industry, Isabelle Ducellier was appointed as the CEO of Swedish probiotics company BioGaia in November 2018. Here, Ducellier highlights her goal of moving the company into the B2B/B2C sector, regulatory obstacles for clinically proven probiotics and BioGaia’s long term strategy.  …

Sweden Johan Wäborg, General Manager Nordic countries at Actelion, shares the importance of Sweden for the group due to its world-class healthcare system and community of experts as well as its national quality and health registries which make the country an ideal environment for early launches and follow-up of treatment outcomes.…

Sweden Founded in Sweden in 2005, and with operations in 13 European countries, Bluefish Pharmaceuticals has become one of the world’s most progressive generic pharmaceuticals companies. CEO Berit Lindholm explains how Bluefish strives to compete on service rather than price by being a reliable partner to health authorities. She also emphasises…

Sweden The National Board of Health and Welfare is the public authority responsible for ensuring that people have access to good health and social care on equal terms in Sweden. Its Director-General, Olivia Wigzell, explains how the Board delivers on this mission, in particular through the development of national care guidelines.…

Sweden Medivir is a Swedish biotech company focusing on the development and commercialization of innovative treatments for cancers of high unmet medical need. Last October, Dr Uli Hacksell was appointed CEO to reorganize the company in order to focus resources on the clinical development of Medivir’s projects. He presents the progress…

Sweden   As one of few Swedish companies, Uppsala-based Orexo has made the leap to commercialize its star product for treating opioid addiction in the US, even before entering the European market. In this interview, CEO Nikolaj Sørensen highlights the impact of Orexo in finding solutions to tackle the US opioid…

Sweden Anna-Kaija Grönblad, country chair Sanofi Sweden and general manager primary care Nordics & Baltics, explains the importance of Sweden for the group as an early adopter of new treatments, an ideal environment for innovative clinical trials and a place where all stakeholders are open to collaborate to find solutions to…

Sweden BioArctic is a Swedish biopharma company with the vision to become a world-leader in the research and development of disease-modifying treatments for patients with neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease, and pioneering treatment methods for complete spinal cord injuries. Gunilla Osswald, CEO, explains how BioArctic is uniquely…

Sweden Orifarm is the largest supplier of parallel imported medicines in the EU and a fast-growing supplier of generic pharmaceuticals in the Nordic countries. Christian Vallentin, country manager of Orifarm Sweden, explains the intricacies of the parallel import business and generics market in Sweden, how to successfully compete in both areas,…

Sweden Bactiguard is a Swedish medtech company with a global presence, offering prevention solutions for nosocomial infections, reducing the use of antibiotics and the spread of multi-resistant bacteria. Its CEO, Christian Kinch, explains how Bactiguard’s solution works to save lives and reduce healthcare costs. He also shares the company’s international journey…